Pharmgate announces appointment of strategic sales team leaders to drive growth

Restructured team positions Pharmgate to support customer needs and meet growing demand

WILMINGTON, N.C. [May 15, 2024] – Pharmgate Animal Health has grown significantly as a trusted animal health provider with a comprehensive product portfolio that puts livestock health first. In response to consistent and significant growth in the U.S. market and with a focus on continuing this growth, the Pharmgate sales team has restructured effective May 1, 2024.

Adam Gutierrez, a key contributor to Pharmgate sales strategies for nine years, has been promoted to sales director of integrator accounts. His new role entails demand creation and oversight of relationships with U.S. production systems and veterinary clinics. Gutierrez’s exceptional leadership and management skills are instrumental in how Pharmgate services large, multi-state accounts in a team environment.


Todd Kelly will transition to sales director of corporate accounts. Since starting with Pharmgate in 2014, he has held various leadership roles, most recently as director of U.S. sales. With his expertise within the animal health industry, Kelly brings a wealth of knowledge and insight that drives sales strategies, helping us stay ahead of market trends and meet customer needs effectively. Kelly will retain his current responsibilities with pricing documentation, distributors, and marketing/agent agreements while spearheading new opportunities and business development.


Together, Gutierrez and Kelly deliver synergies in experience, team building, product, and industry knowledge that enable the Pharmgate U.S. team to continue market growth and expansion.

About Pharmgate Animal Health

Pharmgate Animal Health provides the livestock and poultry industry with a proven portfolio of technically supported, high-quality products that are the foundation of custom herd and flock health protocols. Founded in 2008, the company is headquartered in Wilmington, North Carolina, with FDA-approved pharmaceutical production facilities in Omaha, Nebraska, and CVM vaccine research and manufacturing operations in St. Paul, Minnesota. To learn more about Pharmgate Animal Health or to find a local representative, visit